Regulatory Expectations for Protocol Content in Clinical Trials
Regulatory Expectations for Protocol Content in Clinical Trials A Guide to Regulatory Expectations for Clinical Trial Protocol Content Writing a clinical trial protocol is a highly regulated activity. Regulatory authorities like the USFDA and EMA require strict adherence to content guidelines as outlined in ICH E6(R2) Good Clinical Practice (GCP) and related regulations. Failing to…
Read More “Regulatory Expectations for Protocol Content in Clinical Trials” »